Glycerine

Glycerol

Method of action: Laxative

Treatment option: Sore Throat, Constipation

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glycerine

Property	Description
Active ingredient	Glycerol (Propane-1,2,3-triol)
Form	Suppository, Solution, Ointment, Topical preparations
Pharmacological class	Hyperosmotic Agent, Osmotic Laxative, Humectant
Common use	Relieving minor constipation and soothing dry skin
Origin	Organic compound, naturally derived or synthetic

Chemical Identity and Pharmacological Classification

Glycerine, officially known by its International Nonproprietary Name (INN) Glycerol, is an organic compound chemically defined as a trihydroxy alcohol. As a pharmaceutical agent, it is principally classified as a Hyperosmotic Agent and Osmotic Laxative. This classification is due to its distinctive molecular structure, which facilitates a strong attraction to water.

The compound itself is a colorless, odorless, and distinctly viscous liquid that possesses a sweet taste. While it occurs naturally as a component of fats and oils, Glycerol used in pharmaceutical preparations can be sourced from either natural (plant- or animal-derived) or synthetic origins. Its pharmacological action helps to increase the water content in the stool for easier passage. This means the medicine is clinically recognized for its ability to ease discomfort by gently increasing moisture in the affected area, setting it apart from stimulant laxatives.

Medicinal Forms and General Purpose

The active ingredient remains Glycerol across all its medicinal formats, which include the suppository for rectal administration, liquid solutions, and its extensive use as a humectant in topical preparations and ointments. These distinct dosage form(s) are designed to serve its general therapeutic purpose: providing basic relief by manipulating the water balance in a targeted area.

Glycerol is utilized in these preparations due to its established profile and efficacy as both a topical demulcent and a laxative. Its primary differentiation is that its suppository form provides localized action, often resulting in quicker relief than oral osmotic agents. The medicine is an established agent used for basic hydration and localized water-based softening.

Regulatory References

National Library of Medicine

What side effects are possible with Glycerine?

Possible Side Effects and Safety Information

The regulatory documentation for Glycerol (Glycerine), classified as a hyperosmotic agent and osmotic laxative, structures its safety profile around administration-specific adverse reactions and critical constraints. The frequency and type of documented adverse reactions are primarily related to its localized mechanism of drawing water into the site of application.

Officially Documented Adverse Reactions

Adverse effects are formally classified by frequency in regulatory labeling:

Common Reactions: Adverse events reported with regularity include rectal irritation and flatulence, particularly following suppository use, as well as diarrhea. These effects are often noted as being more frequently observed at the start of treatment or immediately after administration.
Uncommon Reactions: Abdominal cramps have been documented as an uncommon event in some regulatory sources.
Rare Reactions: For topical preparations, rare reports include localized contact dermatitis and other allergic reactions of the skin.

Adverse reactions primarily involve the Gastrointestinal Disorders and General Disorders and Administration Site Conditions system-organ classes.

Serious Safety Considerations and Restrictions

While generally associated with localized, non-serious effects, rectal bleeding is documented in regulatory labeling as a serious adverse event that warrants professional attention.

Safety documents list specific conditions that contraindicate the use of Glycerol suppositories. The medicine should not be used in the presence of existing medical conditions such as known intestinal obstruction, undiagnosed abdominal pain, or symptoms suggestive of appendicitis or gastroenteritis. Furthermore, official labeling advises a specific population-based safety consideration: Glycerol suppositories should not be used in children under 2 years of age unless expressly authorized by a healthcare provider.

Overdose and Emergency Response

Glycerine Overdose and when to seek help

Accidental overdose of Glycerine (Glycerol) is officially associated with two main risks: localized gastrointestinal effects and, with high systemic exposure, severe systemic outcomes. The documented overdose presentations are centered on the gastrointestinal system, which includes nausea, vomiting, diarrhoea, abdominal cramps, and thirst.

Following accidental oral ingestion of a significant quantity, systemic effects may be observed across the Cardiovascular and Neurological systems. Officially listed manifestations include cardiac arrhythmias, dizziness, and mental confusion. Overdose is classified as potentially severe due to the risk of dehydration and electrolyte imbalance, a concern documented by regulatory bodies as being more common in children.

The emergency response is defined by explicit regulatory instruction. If the product is swallowed (accidental oral overdose), the mandated action is to get medical help or contact a Poison Control Center right away. Immediate medical attention is required for clear signs of severe overdose, such as passing out or trouble breathing.

Official management for overdose is symptomatic and supportive treatment. This may involve procedures such as administering intravenous fluids to correct fluid and electrolyte status and may require observation and monitoring of vital signs. The regulatory documentation confirms that there is no specific antidote known.

Therapeutic Uses of Glycerine

Glycerine (or glycerol) is a compound applied across domains where additional symptomatic support is needed, relevant in contexts involving heightened systemic burden. It is commonly used across conditions presenting with acute episodes and conditions involving episodic or fluctuating manifestations, as it helps manage symptoms related to moisture retention and systemic balance.

For internal purposes, glycerine is relevant for easing symptoms that interfere with daily functioning, such as constipation, by providing supportive symptomatic relief. It is utilized as a laxative to address symptoms related to physical discomfort and plays a role in specialized contexts for easing symptoms linked to organ-specific functional stress. Therefore, its primary therapeutic uses are relevant for easing symptoms related to physical discomfort and is applied in addressing symptoms linked to organ-specific functional stress. This action plays a role in managing symptoms related to systemic imbalance and contributes to easing the overall symptom load.

Applied topically, glycerine's properties may assist with managing skin-related symptom clusters associated with dry or inflammatory or irritative states. It provides support that helps ease the overall symptom burden and contributes to improved comfort during symptomatic periods. As a patient benefit, this supportive use helps maintain a sense of stability when symptoms are more noticeable.

“Glycerine is applied in addressing multiple symptom clusters where short-term symptomatic assistance is needed.”

Quick Fact: Support for Symptomatic Constipation

Regulatory References

MedlinePlus overview of Glycerin (rectal route)

Eligibility and Restrictions for Use

The eligibility profile for Glycerine (Glycerol) is strictly defined by regulatory bodies based on specific population restrictions and absolute contraindications.

Absolute Non-Eligibility

The medicine is contraindicated and must not be used by individuals with a confirmed intestinal obstruction or blockage or a known hypersensitivity to glycerol or any of its excipients. Patients experiencing acute abdominal pain, nausea, or vomiting are also strictly advised against use unless directed by a doctor.

Age and Duration Rules

Use is generally permitted for adults and children aged 6 years and over for occasional constipation. However, regulatory standards restrict use in children under 6 years, requiring medical consultation, especially for those under 2 years of age. Use is also strictly limited to a duration of one week; prolonged use is not permitted without medical guidance.

Conditional Use

Certain populations and conditions require mandatory medical consultation. Individuals with diabetes are subject to conditional use as Glycerine may interfere with glucose control. Likewise, patients experiencing a sudden, prolonged change in bowel habits or those who are pregnant or breastfeeding must seek a doctor's advice to determine conditional eligibility.

What should I know about interactions with other medicines?

The regulatory interaction profile for Glycerine (Glycerol suppositories) is highly specific due to its localized osmotic laxative action and minimal systemic absorption. As documented in official government prescribing information, the medicine has a limited number of interaction restrictions, primarily concerning functional and administrative constraints rather than metabolic pathways.

Interaction Restrictions and Cautions

Interaction Category	Regulatory Statement
Pharmacodynamic Restriction	Official prescribing information advises against the concurrent use of other laxatives. This restriction exists to prevent additive effects, which may result in excessive gastrointestinal activity.
Administration Timing Requirement	Timing separation is necessary when administering other rectal preparations. This procedural constraint is in place to ensure local efficacy and minimize the physical displacement of either product.
Systemic Pharmacokinetic Interactions	None documented. Due to the medicine’s poor systemic uptake, regulatory documents report a lack of formal studies and state no known systemic drug-drug interactions related to metabolic enzymes or drug transporters.
Population-Specific Caution	A specific warning is included for patients with diabetes, as the use of Glycerine may interfere with glucose control.
Food, Alcohol, Supplements	No known interactions with food or drinks are documented. The regulatory status regarding alcohol consumption is generally stated as unknown.

Connection to the overall interaction profile: The official interaction profile is defined by functional and procedural restrictions for co-administered agents, reflecting the local nature of the product's action. The lack of documented systemic pharmacokinetic constraints (e.g., CYP or transporter effects) minimizes concerns regarding co-administration with most systemic medicines.

Mechanism of Action

Glycerine functions as a low-molecular-weight triol that readily penetrates the stratum corneum. It is a hygroscopic substance, binding and retaining water molecules via three hydroxyl groups to increase the water content within the stratum corneum. Glycerine molecules form hydrogen bonds with beta-keratin and inter-filamental proteins, increasing the flexibility and reducing the packing density of the lipid matrix within the stratum corneum, which reduces water molecule diffusion. The elevated water concentration modulates the activity of hydrolytic enzymes involved in desquamation. Glycerine also serves as an endogenous osmolyte, facilitating water transport by binding to the glycerol channels, notably Aquaporin-3 (AQP3), within the epidermal cell membranes. This collective action modifies the mechanical and structural properties of the epidermal barrier.

Dosage and Administration Information

The official usage of Glycerine (Glycerol) is strictly defined by its pharmaceutical form and administration route, as detailed in prescribing information. The medicine is primarily administered via the rectal route as a suppository, orally as a specialized solution, or topically for skin application.

Administration Patterns and Dosing

Route and Form	Standard Adult Regimen	Frequency and Duration Constraint
Rectal Suppository	One suppository (e.g., 2 g strength) is inserted rectally.	Administered as a single daily dose when needed, and its use should not extend beyond one week without professional direction.
Oral Solution (Prescription)	Initial dose of 1 to 2 grams per kilogram (kg) of body weight.	Dosing is controlled, calculated based on weight, and may be repeated at six-hour intervals if necessary for its intended specialized use.
Topical Liquid/Ointment	Applied externally to the affected area as needed.	For external use only.

Population and Procedural Rules

Administration rules vary by age. Children aged 6 years and older typically follow the adult suppository dosage. However, children aged 2 to under 6 years require a lower, specifically labeled pediatric strength suppository for once-daily use. Use in children under 2 years must be directed by a healthcare professional.

For the prescription oral solution, administration may involve mixing the dose with unsweetened citrus juice and sipping it over cracked ice to improve intake conditions. The suppository must be inserted well up into the rectum, confirming it is for rectal use only and is not to be taken by mouth.

Recent Clinical Evidence

Research evidence / Overview of studies for Glycerine

Evidence for Short-Term Relief of Occasional Constipation

Research related to this laxative use was studied for its application in conditions associated with acute or disruptive episodes of constipation. The evidence base includes established regulatory evidence, Retrospective Reviews, and specialized physiological research. These physiological studies monitored outcomes related to physical discomfort, such as the acute timing of the onset of bowel movements and specific muscular activity in the colon. These studies have primarily focused on research exploring short-term symptom changes related to episodic constipation. Findings describe patterns observed in the studies regarding a rapid onset of activity, which contributes to the broader evidence landscape where short-term, episodic patterns were studied. This research describes short-term changes in colonic function that were monitored in the studies.

The published research includes older data, and large-scale Randomized Controlled Trials (RCTs) covering the general adult population are limited. There is limited information for long-term outcomes regarding the repeated or chronic use of Glycerine.

Evidence for Topical Use in Dry Skin and Barrier Function

This part outlines the research landscape for topical Glycerine, covering studies such as Randomized Controlled Trials (RCTs) that have measured objective outcomes like skin hydration (Stratum Corneum capacitance) and skin barrier integrity (Transepidermal Water Loss).

The topical use of Glycerine was evaluated in studies examining patient-reported experiences for conditions characterized by functional limitations of the skin barrier, such as dry skin and Atopic Dermatitis. Researchers examined objective skin biomarkers like Transepidermal Water Loss (TEWL) and skin hydration measurements. Research highlights changes measured during the study period in skin hydration and barrier function measurements when compared to a control product. However, for specific outcomes, such as overall clinical severity scores, findings were mixed when compared directly to the control vehicle. Long-term effects are not fully established regarding the maintenance of barrier function and hydration beyond the study period.

What Remains Uncertain About the Research

The evidence base highlights several areas where knowledge is incomplete. Evidence quality varies across studies, and for highly specialized neonatal use (e.g., in premature infants), certainty remains low due to inconsistent results and methodological limitations. Long-term effects are not fully established for chronic use in either the topical or rectal applications, as follow-up durations were limited in most trials. Furthermore, comparative evidence is lacking in several areas of research.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Glycerine (FAQ)

Q: Can frequent use of Glycerine cause the skin to become dependent on it?

A: Official information for the suppository form indicates that prolonged or frequent use may potentially lead to a dependence on the laxative effect, resulting in the loss of normal bowel function. Official instructions limit use to occasional constipation and generally restrict it to short durations, typically not extending beyond one week unless directed by a healthcare provider.

Q: What happens if you use a Glycerine suppository for too many days in a row?

A: Official labeling indicates the product is for short-term use only in relieving occasional constipation. Its duration of use is typically limited to one week, and prolonged use requires consultation with a healthcare provider. Continuous use may interfere with normal bowel function.

Q: Is it normal to feel a mild burning sensation after applying Glycerine to the skin?

A: When using the suppository form, regulatory documents note that potential side effects can include a sensation of rectal discomfort or a mild burning feeling. These are generally localized effects. If discomfort is persistent or severe, it is best to consult with a healthcare professional.

Q: Can Glycerine interact with blood pressure medication?

A: For the suppository form, official prescribing information states there are no known systemic drug-drug interactions related to metabolic enzymes or drug transporters. Because of this minimal absorption, the suppository form is reported in regulatory documents to have no known systemic drug-drug interactions, lessening the concern for interaction with systemic medicines like those for blood pressure.

Q: Does the body absorb Glycerine when it's applied topically?

A: When taken orally, Glycerol is readily absorbed from the intestine and then metabolized by the body. However, regulatory information for the rectal suppository form notes that there is minimal systemic absorption into the bloodstream.

Q: Is it safe to use Glycerine during pregnancy?

A: Official labeling advises that people who are pregnant or are nursing a baby should consult with a doctor or other healthcare provider before using the product. A healthcare provider must be consulted to determine eligibility and to advise on the appropriate use during pregnancy or breastfeeding.

Q: What are the signs that I might be allergic to Glycerine?

A: Signs of an allergic reaction warrant immediate cessation of use and consultation with a healthcare provider. These signs, documented in official sources, may include hives, a rash, itching, or swelling of the face, lips, tongue, or throat.

Q: Is there a link between using Glycerine and dehydration?

A: Oral Glycerol may cause severe dehydration in previously dehydrated patients. This caution is primarily associated with the high-dose oral prescription solution, where the risk of severe dehydration in susceptible patients has been noted.

Q: Does Glycerine have any impact on blood sugar levels when applied topically?

A: Oral Glycerol may cause hyperglycemia, or high blood sugar. For all forms, patients with diabetes are subject to caution as Glycerine may interfere with glucose control. Consulting with a healthcare provider is necessary for individuals with diabetes before using the product.

Q: Is it normal to experience mild cramping with a Glycerine laxative?

A: Abdominal discomfort and cramping are documented as a potential side effect of the suppository form. These effects are often noted as being more frequently observed at the start of treatment or immediately after administration.

Q: Are there any known drug-food interactions related to Glycerine?

A: Regulatory documents for the suppository form state that there are no known interactions with food or drinks. This indicates that timing the administration of the suppository in relation to meals is not a documented concern.

How should Glycerine be stored and disposed of?

How to Store and Dispose of Glycerine

The storage and disposal of pharmaceutical Glycerine (Glycerol) are defined by strict regulatory requirements to maintain product stability and ensure safety.

Official Storage Requirements

Glycerine products must be stored at controlled room temperature, generally below 30 C (86 F), as specified in the official labeling. The container must be kept tightly closed and stored in a cool, dry place to protect the hygroscopic substance from moisture and light. All medicinal forms must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Glycerine must be disposed of according to local, regional, and national regulations for pharmaceutical waste. The product must not be allowed to enter drains, sewers, or surface water to comply with environmental protection requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Greece

Lebanon

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z